Skip to main content
. 2018 May 2;9(5):502. doi: 10.1038/s41419-018-0519-8

Table 2.

Characteristics of APOSC implantation in each patient

Characteristics Patient #1 Patient #2 Patient #3 Patient #4 Patient #5 Patient #6
A. S/S Rt hemiparesis Rt hemiparesis Rt hemiparesis Lt hemiparesis Lt hemiparesis Lt hemiparesis
B. MRI-T2WI graphic file with name 41419_2018_519_Figa_HTML.gif graphic file with name 41419_2018_519_Figb_HTML.gif graphic file with name 41419_2018_519_Figc_HTML.gif graphic file with name 41419_2018_519_Figd_HTML.gif graphic file with name 41419_2018_519_Fige_HTML.gif graphic file with name 41419_2018_519_Figf_HTML.gif
C. Stroke history (months) 51 11 12 16 20 29
D. No. of injected cells 2 × 106 2 × 106 2 × 106 2 × 106 2 × 106 2 × 106
E. Purity of p75+ cells 91.5 % 90.4 % 95.5 % 91.7 % 91 % 91%
F. No. of IC trajectory 3 3 3 3 3 3

S/S symptoms and signs, MRI-T2* T2* image in MRI, No. numbers, Lt left limbs, Rt right limbs, y years, IC intracerrbral